Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11.02 Billion CNY | 3.71% |
| 2022 | 10.63 Billion CNY | 14.59% |
| 2021 | 9.28 Billion CNY | 5.35% |
| 2020 | 8.8 Billion CNY | 8.57% |
| 2019 | 8.11 Billion CNY | 14.01% |
| 2018 | 7.11 Billion CNY | 18.48% |
| 2017 | 6 Billion CNY | 35.17% |
| 2016 | 4.44 Billion CNY | 20.61% |
| 2015 | 3.68 Billion CNY | 28.27% |
| 2014 | 2.87 Billion CNY | 93.45% |
| 2013 | 1.48 Billion CNY | 87.45% |
| 2012 | 792.19 Million CNY | 62.19% |
| 2011 | 488.44 Million CNY | 21.36% |
| 2010 | 402.48 Million CNY | 13.9% |
| 2009 | 353.35 Million CNY | 36.36% |
| 2008 | 259.13 Million CNY | -7.81% |
| 2007 | 281.09 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 9.88 Billion CNY | -10.39% |
| 2024 Q3 | 8.31 Billion CNY | -3.68% |
| 2024 Q2 | 8.62 Billion CNY | -12.69% |
| 2023 Q4 | 11.02 Billion CNY | 7.39% |
| 2023 Q2 | 10.88 Billion CNY | 0.37% |
| 2023 FY | 11.02 Billion CNY | 3.71% |
| 2023 Q3 | 10.27 Billion CNY | -5.67% |
| 2023 Q1 | 10.84 Billion CNY | 2.0% |
| 2022 Q2 | 9.59 Billion CNY | 0.14% |
| 2022 Q3 | 9.89 Billion CNY | 3.07% |
| 2022 FY | 10.63 Billion CNY | 14.59% |
| 2022 Q4 | 10.63 Billion CNY | 7.49% |
| 2022 Q1 | 9.58 Billion CNY | 3.29% |
| 2021 Q3 | 8.82 Billion CNY | 0.53% |
| 2021 Q4 | 9.28 Billion CNY | 5.21% |
| 2021 Q1 | 8.61 Billion CNY | -2.17% |
| 2021 FY | 9.28 Billion CNY | 5.35% |
| 2021 Q2 | 8.77 Billion CNY | 1.81% |
| 2020 Q3 | 8.86 Billion CNY | 7.97% |
| 2020 Q1 | 7.53 Billion CNY | -7.13% |
| 2020 Q4 | 8.8 Billion CNY | -0.58% |
| 2020 Q2 | 8.2 Billion CNY | 8.89% |
| 2020 FY | 8.8 Billion CNY | 8.57% |
| 2019 Q3 | 7.52 Billion CNY | -2.78% |
| 2019 Q1 | 7.89 Billion CNY | 10.87% |
| 2019 Q4 | 8.11 Billion CNY | 7.78% |
| 2019 FY | 8.11 Billion CNY | 14.01% |
| 2019 Q2 | 7.74 Billion CNY | -1.86% |
| 2018 Q2 | 7.19 Billion CNY | 7.3% |
| 2018 Q1 | 6.7 Billion CNY | 11.56% |
| 2018 FY | 7.11 Billion CNY | 18.48% |
| 2018 Q3 | 7.2 Billion CNY | 0.13% |
| 2018 Q4 | 7.11 Billion CNY | -1.15% |
| 2017 Q2 | 5.01 Billion CNY | 5.77% |
| 2017 FY | 6 Billion CNY | 35.17% |
| 2017 Q4 | 6 Billion CNY | 11.34% |
| 2017 Q3 | 5.39 Billion CNY | 7.56% |
| 2017 Q1 | 4.74 Billion CNY | 6.71% |
| 2016 Q4 | 4.44 Billion CNY | 1.98% |
| 2016 Q1 | 3.51 Billion CNY | -4.61% |
| 2016 Q2 | 4.18 Billion CNY | 18.99% |
| 2016 FY | 4.44 Billion CNY | 20.61% |
| 2016 Q3 | 4.35 Billion CNY | 4.2% |
| 2015 Q3 | 3.62 Billion CNY | 6.94% |
| 2015 FY | 3.68 Billion CNY | 28.27% |
| 2015 Q1 | 3.02 Billion CNY | 5.46% |
| 2015 Q4 | 3.68 Billion CNY | 1.63% |
| 2015 Q2 | 3.39 Billion CNY | 11.91% |
| 2014 Q1 | 1.47 Billion CNY | -0.96% |
| 2014 FY | 2.87 Billion CNY | 93.45% |
| 2014 Q4 | 2.87 Billion CNY | 13.72% |
| 2014 Q3 | 2.52 Billion CNY | 19.55% |
| 2014 Q2 | 2.11 Billion CNY | 43.68% |
| 2013 FY | 1.48 Billion CNY | 87.45% |
| 2013 Q2 | 855.04 Million CNY | 3.81% |
| 2013 Q3 | 1.17 Billion CNY | 37.2% |
| 2013 Q1 | 823.66 Million CNY | 3.97% |
| 2013 Q4 | 1.48 Billion CNY | 26.58% |
| 2012 Q3 | 648.85 Million CNY | -5.67% |
| 2012 Q1 | 521.32 Million CNY | 6.73% |
| 2012 Q2 | 687.87 Million CNY | 31.95% |
| 2012 Q4 | 792.19 Million CNY | 22.09% |
| 2012 FY | 792.19 Million CNY | 62.19% |
| 2011 Q3 | 351.37 Million CNY | -6.64% |
| 2011 FY | 488.44 Million CNY | 21.36% |
| 2011 Q4 | 488.44 Million CNY | 39.01% |
| 2011 Q1 | 311.74 Million CNY | -22.54% |
| 2011 Q2 | 376.37 Million CNY | 20.73% |
| 2010 FY | 402.48 Million CNY | 13.9% |
| 2010 Q4 | 402.48 Million CNY | 31.21% |
| 2010 Q3 | 306.75 Million CNY | -15.6% |
| 2010 Q2 | 363.43 Million CNY | 0.0% |
| 2009 FY | 353.35 Million CNY | 36.36% |
| 2009 Q4 | 353.35 Million CNY | 0.0% |
| 2008 FY | 259.13 Million CNY | -7.81% |
| 2007 FY | 281.09 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 8.75 Billion CNY | -25.948% |
| ZJAMP Group Co., Ltd. | 12.99 Billion CNY | 15.117% |
| Luyan Pharma Co.,Ltd. | 8.81 Billion CNY | -25.097% |
| Ji Yao Holding Group Co., Ltd. | 2.72 Billion CNY | -305.351% |